2seventy bio, Inc. (TSVT)
May 13, 2025 - TSVT was delisted (reason: acquired by BMY)
5.00
0.00 (0.00%)
Inactive · Last trade price on May 12, 2025

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Treatments for Cancer
100.39M
Log In
Log In
Log In
Log In
Treatments for Cancer Growth
9.72%
Log In
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
United States
100.39M
Log In
Log In
Log In
Log In
United States Growth
9.72%
Log In
Log In
Log In
Log In